Hochschulschrift
Baseline and on-treatment markers determining prognosis of first-line chemotherapy in combination with bevacizumab in patients with metastatic colorectal cancer
- Sprache
-
Deutsch
- Umfang
-
23 Blätter
- Maße
-
30 cm
- Anmerkungen
-
Diagramme
Literaturverzeichnis: Blätter 18-22
Universität Hamburg, Dissertation, 2018
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Schlagwort
-
Krebs
- Urheber
-
Denne, Laura Elisabeth
- Ereignis
-
Veröffentlichung
- (wo)
-
Hamburg
- (wann)
-
[2018]
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 12:13 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Denne, Laura Elisabeth
Entstanden
- [2018]
Ähnliche Objekte (12)
Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer : an individual patient data based meta-analysis
Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival
Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy
Bevacizumab for patients with recurrent multifocal glioblastomas
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Adrenal insufficiency in patients with corticosteroid-refractory cerebral radiation necrosis treated with bevacizumab
Bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups
Chemotherapy under special conditions : [with] 41 tab.
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients
Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer : an individual patient data based meta-analysis
Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival
Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy
Bevacizumab for patients with recurrent multifocal glioblastomas
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Adrenal insufficiency in patients with corticosteroid-refractory cerebral radiation necrosis treated with bevacizumab
Bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups
Chemotherapy under special conditions : [with] 41 tab.
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients
Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer : an individual patient data based meta-analysis
Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival
Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy
Bevacizumab for patients with recurrent multifocal glioblastomas
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Adrenal insufficiency in patients with corticosteroid-refractory cerebral radiation necrosis treated with bevacizumab
Bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups
Chemotherapy under special conditions : [with] 41 tab.
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment